Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 10, 2003 - Issue 3
150
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Research Accountability and Financial Conflicts of Interest in Industry Sponsored Clinical Research: A Review

Pages 137-158 | Published online: 08 Sep 2010

  • American Association of Medical Colleges (AAMC) . 2002 . Protecting subjects, preserving trust, promoting progress II: Principles and recommendations for oversight of an institution's financial interests in human subjects research . October Available at http://www.aamc.org/members/coitf/.
  • Andrews , L. B. 2000 . Money is putting people at risk in biomedical research . Chronicle of Higher Education , 10 March : B4
  • Angell , M. 2000 . Is academic medicine for sale? . New England Journal of Medicine , 342 : 508 – 510 .
  • 2003a . JAMA Decries Early End to Study . Wall Street Journal , 23 April : D4 Associated Press
  • Associated Press. (6/9/2003a). Harvard may relax policies on financial ties to drug companies [cited 9 June 2003]. Available from http://www.boston.com.
  • Association of American Universities . October 2001a . Task Force on Research Accountability , Report on individual and institutional financial conflicts of interest October ,
  • Association of American Universities . 2001b . Framework document on Managing Financial Coi's . October [cited May 1993] Available from http://www.aau.edu/reports/ frwkCOI'S.html
  • AUTM Licensing Survey FY . 1999 . Survey Summary. , 17 Northbrook, Ill : Association of University Technology Managers 2000 .
  • Bekelman , J. E. , Yan , L. and Gross , C. P. 2003 . Scope and impact of financial coi's in biomedical research. . The Journal of the American Medical Association , 289 : 454 – 65 .
  • Bero , L. A. and Rennie , D. 1996 . Influences on the quality of published drug studies . Int J Technol Assess Health Care , 12 (2) : 209 – 37 .
  • Birch , D. M. and Cohn , G. 24 June 2001a . How a cancer trial ended in betrayal with billions at stake, research universities become partners in commerce-and medicine pays a price. , Series: Of patients and profits 24 June , WL 6162959 : The Baltimore Sun .
  • Birch , D. M. and Cohn , G. 25 June 2001b . The changing creed of Hopkins science. What once was heresy is now the mission: a partnership with business to advance research , Series: Of profits and patients 25 June , WL 6162994 : The Baltimore Sun .
  • Birch , D. M. and Cohn , G. 26 June 2001c . Standing up to industry as corporations increasingly hold their purse strings, many researchers feel pressed to deliver favorable results , 26 June , WL 6163085 : Baltimore Sun .
  • Blumenthal , D. 1997 . Withholding research results in academic life science: With holding evidence from a national survey of faculty. . The Journal of the American Medical Association , 277 : 1224 – 8 .
  • Blumenthal , D. , Campbell , D. G. , Causion , N. and Seashore , L. K. 1996 . Participation of life-science faculty in research relationships with industry . New England Journal of Medicine , 335 : 1734 – 9 .
  • Board , W. and Wade , N. 1982 . Betrayers of the truth. , New York : Simon and Schuster .
  • Bodenheimer , T. 2000 . Uneasy alliance-clinical investigators and the pharmaceutical industry . New England Journal of Medicine , 342 : 1539 – 44 .
  • Boyd , E. and Bero , L. 2000 . Assessing faculty financial relationships with industry: A case study. . The Journal of the American Medical Association. , 184 : 2209 – 14 .
  • Brennan , T. A. 1994 . Buying editorials. . New England Journal of Medicine. , 331 (10) : 673 – 5 .
  • Bruce , M. P. and Rennie , D. 2003 . Stopping medical research to save money. . A broken pact with researchers and patients. The Journal of the American Medical Association. , 289 : 2128 – 31 .
  • Bulkeley , W. M. 2000 . Publication broke rules on disclosure . Wall Street Journal , 24 February WLWSJ 3019181
  • Chalmers , I. 1990 . Underreporting research is scientific misconduct. . The Journal of the American Medical Association , 263 : 105 – 8 .
  • Chaudhry , S. , Schroter , S. , Smith , R. , DeAngelis , C. , Drazen , J. , Hoey , J. , Hojgaard , L. , Horton , R. , Kotzin , S. , Nicholls , M. , Nylenna , M. , Overbeke , A. , Sox , H. , Van Der Weyden , M. and Wilkes , M. 2002 . Does declaration of competing interests affect readers' perceptions? A randomized trial. . BMJ , 325 : 1391 – 2 .
  • Cho , M. , Shohara , R. , Schissel , A. and Drummond , R. 2000 . Policies on faculty coi's at U.S. universities. . The Journal of the American Medical Association. , 284 (1) : 2203 – 8 .
  • Council on Governmental Relations . 1999 . The Bayh-Dole Act: A Guide to the Law and Implementing Regulations . September
  • Davidoff , F. and others . 2001 . Sponsorship, authorship, and accountability. . New England Journal of Medicine. , 343 : 1621 – 6 .
  • Davidson , R. A. 1986 . Source of funding and outcome of clinical trials. . Journal of General Internal Medicine. , 1 : 155 – 8 .
  • DeAngelis , C. D. 2000 . Coi's and the public trust . The Journal of the American Medical Association , 284 : 2237 – 8 . (And articles cited therein)
  • Department of Health and Human Services (DHHS) . 2003 . Draft "Financial relationships and interest in research involving human subjects: guidance for human subject protection . 31 March
  • Drazen , J. M. 2002 . Institutions, contracts, and academic freedom. . New England Journal of Medicine. , 347 : 132 – 1363 .
  • Drazen , J. M. and Curfman , G. 2002 . Financial associations of authors. . New England Journal of Medicine. , 346 (24) : 1901 – 2 .
  • Duecker , K. S. 1997 . Biobusiness on campus: Commercialization of university-developed biomedical technologies . Food and Drug L J. , 52 : 453
  • Emanuel , E. and Steiner , D. 1995 . Institutional conflict of interest. . New England Journal of Medicine. , 332 : 262 – 7 .
  • Flanagin , A. , Carey , L. A. , Fontanarosa , P. B. , Phillips , S. , Pace , B. , Lundberg , G. and Rennie , D. 1998 . Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. . The Journal of American Medical Association. , 280 : 222 – 4 .
  • Food and Drug Administration (FDA) . 2001 . Guidance for industry: Choice of control group and related issues in clinical trials .
  • Friedberg , M. , Saffran , B. , Stinson , T. J. , Nelson , W. and Benn , C. L. 1999 . Evaluation of coi's in economic analyses of new drugs used in oncology. . The Journal of American Medical Association. , 282 : 1453 – 7 .
  • General Accounting Office (GAO) . 2001 . Report to the ranking minority member. Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions . U.S. Senate , November GAO-02-89
  • Guidelines for Dealing with Faculty Conflicts of Commitment and Coi's in Research. (1990) , Washington DC : AAMC .
  • Guterman , L. 2001 . 12 medical journals issue joint policy on research supported by business . Chronicle of Higher Education , 5 October
  • Harvard Medical School Office of Public Affairs . 2001 . News release. Leading NIH-funded medical schools agree on guidelines that would strengthen coi's policies of virtually all schools, hospitals, and research institutes [cited 8 February]. Available from: http://www.hms.harvard.edu/news/releases/020901 conflict.html. Consensus statement on co's policies for academic institutions. Available from http:// www.hms.harvard.edu/news/releases/conflictguidelines.html
  • 1990 . Hippocrates Meets Mammon . The Economist Newspaper Ltd , September 22 : 95
  • International Committee of Medical Journal Editors . 2001 . Uniform requirements for manuscripts submitted to biomedical journals . Available at http://www.icmje.org
  • Kelves , D. J. 2001 . Principles, property rights, and profits: Historical reflections on university/industrial tensions. . Accountability in Research , 8 (4) : 293 – 307 .
  • Krimsky , S. 1999 . Coi's and cost-effectiveness analysis. . The Journal of American Medical Association , 282 : 1474 – 5 .
  • Krimsky , S. and Rothenberg , L. S. 2001 . Coi's policies in science and medical journals: editorial practices and author disclosures. . Science and Engineering Ethics. , 7 : 205 – 18 .
  • Krimsky , S. , Rothenberg , L. S. , Stott , P. and Kyle , G. 1998 . Scientific journals and their authors' financial interests: a pilot study. . Psychother. Psychosom. , 67 : 194 – 201 .
  • Kuszler , P. C. 2001 . Curing coi's in clinical research: Impossible dreams and harsh realities . Widener L. Symp. J. , 8 : 115
  • Lawrence , Arthur J. 2001 . Assistant Surgeon General from Mary Faith Marshall . Chairperson for NHRPA, 23 August correspondence available from http://ohrp.osophs.dhhs.gov/nhrpac/doc≍report.htm
  • Lexchin , J. , Bero , L. A. , Djulbegovic , B. and Clark , O. 2003 . Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. . BMJ. , 326 : 1167 – 70 .
  • Lo , B. , Wolf , L. E. and Berkeley , A. 2000 . Conflict-of-interest policies for investigators in clinical trials. . New England Journal of Medicine , 343 : 1616 – 20 .
  • Maatz , C. T. 1993 . University physician-research coi's: The inadequacy of current controls and proposed reform. . High Tech. L. J. , 7 : 137 – 88 .
  • Martin , J. and Kasper , D. L. 2000 . In whose best interest? Breaching the academic-industrial wall. . New England Journal of Medicine , 343 : 2646 – 9 .
  • McCrary , S. V. , Anderson , C. B. Jakovlijevic , J. 2000 . A national survey of policies on disclosure of coi's in biomedical research. . New England Journal of Medicine , 343 : 1621 – 6 .
  • Miller , F. H. 2001 . Trusting doctors: Tricky business when it comes to clinical research. . B.U.L. Rev. , 81 : 421 – 43 .
  • Moses , H. and Martin , J. B. 2001 . Academic relationships with industry: A new model for biomedical research. . The Journal of American Medical Associates , 285 : 933 – 5 .
  • Nathan , D. G. and Weatherall , D. J. 2002 . Academic freedom in clinical research. . New England Journal of Medicine , 347 (17) : 1368 – 71 .
  • National Institutes of Health (NIH) . 2000 . Conference on Human Subject Protection and Financial Conflicts of Interest Transcript. J Sugarman. Raising Ethical Questions Concerning Conflict of Interest Throughout the Process of Clinical Research [cited 16 August] . Available from http://ohrp.osophs.dhhs.gov/coi8-15.html
  • Office of Inspector General . 2000 . Recruiting human subjects: sample guidelines for practice . : 1 – 23 .
  • Office of Inspector General . 2000 . Recruiting human subjects: pressures in industry sponsored clinical research . June : 1 – 79 .
  • PhRMA adopts principles for conduct of clinical trials and communication of clinical trial results. (2001). Available from http://www.phrma.org.
  • Public Health Service . 1995 . Responsibility of applicants for promoting objectivity in research. http://grants.nih.gov/grants/guide/notice-files/not95-179.html
  • Public Health Service . 2001 . Draft interim guidance. Financial relationships in clinical research: Issues for institutions, clinical investigators, and IRBs to consider when dealing with issues of financial conflicts of interests and human subject protection [cited 10 January 2001] . Available from http://ohrp.osophs.dhhs.gov/nhrpac/mtg12-00/finguid.html
  • Rochon , P. A. , Berger , P. B. and Gordon , M. 1998 . The evolution of clinical trials: Inclusion and representation. . CMAJ , 159 : 1372 – 4 .
  • Rodwin , M. 1993 . Medicine, money, and morals , 225 Oxford University Press .
  • Schulman , K. A. , Seils , D. M. Timbie , J. W. 2002 . A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. . New England Journal of Medicine. , 347 (17) : 1335 – 41 .
  • Shamoo , A. E. and Resnik , D. B. 2003 . Responsible Conduct of Research. , London : Oxford University Press .
  • Spece , R. G. , Shim , D. S. and Buchanan , A. E. 1996 . Conflicts of interest in clinical practice and research. , New York : Oxford University Press .
  • Stelfox , H. T. , Chua , G. , O'Rourke , K. and Detsky , A. S. 1998 . Coi's in the debate over calcium-channel antagonists. . New England Journal of Medicine , 338 : 101 – 6 .
  • Stolberg , S. G. 2000 . Teenager's death is shaking up field of human gene-therapy experiments . New York Times , 27 January WL 12394777
  • Stolberg , S. G. 2001 . Scientists often mum about ties to industry . New York Times , 25 April
  • Tereskerz, P. M. and J. D. Moreno (n.d.) Ten Steps to Developing a National Agenda to Address Financial Coi's in Industry Sponsored Clinical Research. Submitted for publication.
  • Thompson , J. , Baird , P. and Downie , J. 2002 . Report of the committee of inquiry on the case involving Dr. Nancy Olivieri, the Hospital for Sick Children, the University of Toronto, and Apotex Inc. Toronto: Canadian Association of University Teachers, 2001 cited in Nathan, DG and Weatherall DJ. Academic Freedom in Clinical Research. . New England Journal of Medicine , 347 : 1368 – 71 .
  • Tilden , V. P. 2000 . Preventing scientific misconduct-times have changed. . Nursing Research , 49 (5) : 243
  • Wolfe , S. 2000 . Transcript. Conference on Human Subject Protection and Financial Coi's. Plenary Presentation [cited 16 August 2000] . Transcript. Available from http://ohrp.osophs.dhhs.gov/coi's8-16.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.